We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Biochemical Parameters Compared for Diabetic Ketoacidosis Severity

By LabMedica International staff writers
Posted on 19 Jan 2022
Print article
Image: The D-3-Hydroxybutyrate (Ranbut) assay is a superior marker of ketoacidosis (Photo courtesy of Randox)
Image: The D-3-Hydroxybutyrate (Ranbut) assay is a superior marker of ketoacidosis (Photo courtesy of Randox)
Diabetic ketoacidosis (DKA) is a life-threatening acute complication of diabetes mellitus characterized by hyperglycemia and ketoacidosis. It can occur in both type 1 diabetes (T1DM) and type 2 (T2DM) diabetes patients under stress conditions.

Laboratory findings in DKA consist of hyperglycemia, high anion gap metabolic acidosis, and detection of serum ketone or urine ketone bodies. Three types of ketone bodies, acetoacetate, beta-hydroxybutyrate (BHB), and acetone, are produced in DKA. The ratio of BHB to acetoacetate in patients with DKA is increased by 10 times compared with the healthy population.

Endocrinologists at the Maharaj Nakorn Si Thammarat Hospital (Muang, Thailand) and their colleagues recruited 99 patients with type 1 or type 2 diabetes mellitus that were diagnosed with DKA between October 1, 2018 and September 30, 2020 into a prospective observational study. The inclusion criteria were: age > 18 years, diagnosed with DKA and admitted to the hospital, serum blood glucose ≥250 mg/dL and serum BHB ≥3 mmol/L, and venous blood pH < 7.3 or serum bicarbonate < 18 mmol/L.

Serum BHB was measured by an enzymatic method, the Ranbut assay, (Randox Laboratories Limited, Crumlin, UK). The test was linear for serum BHB at 0.1–5.75 mmol/L and had a correlation coefficient of r = 0.9954. Serum glucose, blood urea nitrogen (BUN), creatinine, serum lactate, and serum electrolytes were measured using a c501 module of the Cobas 6000 analyzer series (Roche Diagnostics, Rotkreuz, Switzerland).

The investigators reported a total of 99 diabetes patients were diagnosed with DKA (mean age 39.4 years, 63.4% female, 53.6% T2DM). while infection was the most common precipitating factor in T2DM (43.4%), non-compliance with treatment was the most common precipitating factor in T1DM (43.5%). The initial laboratories evaluation of patients did not significant differ between type1 and type2 diabetes. Serum BHB during treatment of DKA was significantly correlated with changes in serum bicarbonate, serum anion gap, and venous pH. The serum BHB levels corresponding to HCO3 levels for DKA severity were 4.5, 5.7, and 5.9 mmol/L in mild, moderate, and severe DKA, respectively. The serum BHB level of < 1 mmol/L had 73.7% sensitivity and 100% specificity to predict DKA resolution. Median time to resolution of DKA was 12 hours with an optimized BHB cut-off value of < 1 mmol/L. There were no significant difference in time to resolution of DKA in the patients with type 1 and type 2 diabetes.

The authors concluded there are no differences in DKA-related biochemical parameters between type 1 and type 2 diabetes patients. The present findings suggest that DKA should be assessed and treated similarly, regardless of its occurrence in type 1 or type 2 diabetes patients. The study was published on January 6, 2022 in the journal BMC Endocrine Disorders.

Related Links:
Maharaj Nakorn Si Thammarat Hospital
Randox Laboratories
Roche Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.